These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 23316481)

  • 21. Unprecedented Melioidosis Cases in Northern Australia Caused by an Asian Burkholderia pseudomallei Strain Identified by Using Large-Scale Comparative Genomics.
    Price EP; Sarovich DS; Smith EJ; MacHunter B; Harrington G; Theobald V; Hall CM; Hornstra HM; McRobb E; Podin Y; Mayo M; Sahl JW; Wagner DM; Keim P; Kaestli M; Currie BJ
    Appl Environ Microbiol; 2016 Feb; 82(3):954-63. PubMed ID: 26607593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Melioidosis vaccines: a systematic review and appraisal of the potential to exploit biodefense vaccines for public health purposes.
    Peacock SJ; Limmathurotsakul D; Lubell Y; Koh GC; White LJ; Day NP; Titball RW
    PLoS Negl Trop Dis; 2012 Jan; 6(1):e1488. PubMed ID: 22303489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective efficacy of heat-inactivated B. thailandensis, B. mallei or B. pseudomallei against experimental melioidosis and glanders.
    Sarkar-Tyson M; Smither SJ; Harding SV; Atkins TP; Titball RW
    Vaccine; 2009 Jul; 27(33):4447-51. PubMed ID: 19490962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Burkholderia pseudomallei Δasd mutant exhibits attenuated intracellular infectivity and imparts protection against acute inhalation melioidosis in mice.
    Norris MH; Propst KL; Kang Y; Dow SW; Schweizer HP; Hoang TT
    Infect Immun; 2011 Oct; 79(10):4010-8. PubMed ID: 21807903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Melioidosis: Clinical impact and public health threat in the tropics.
    Perumal Samy R; Stiles BG; Sethi G; Lim LHK
    PLoS Negl Trop Dis; 2017 May; 11(5):e0004738. PubMed ID: 28493905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenesis of and immunity to melioidosis.
    Brett PJ; Woods DE
    Acta Trop; 2000 Feb; 74(2-3):201-10. PubMed ID: 10674650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive approaches for the detection of Burkholderia pseudomallei and diagnosis of melioidosis in human and environmental samples.
    Oslan SNH; Yusoff AH; Mazlan M; Lim SJ; Khoo JJ; Oslan SN; Ismail A
    Microb Pathog; 2022 Aug; 169():105637. PubMed ID: 35710088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Consensus on the development of vaccines against naturally acquired melioidosis.
    Limmathurotsakul D; Funnell SG; Torres AG; Morici LA; Brett PJ; Dunachie S; Atkins T; Altmann DM; Bancroft G; Peacock SJ;
    Emerg Infect Dis; 2015 Jun; 21(6):. PubMed ID: 25992835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of Reverse Vaccinology in the Design and Construction of Nanoglycoconjugate Vaccines against Burkholderia pseudomallei.
    Muruato LA; Tapia D; Hatcher CL; Kalita M; Brett PJ; Gregory AE; Samuel JE; Titball RW; Torres AG
    Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28903988
    [No Abstract]   [Full Text] [Related]  

  • 30. Boosting of post-exposure human T-cell and B-cell recall responses in vivo by Burkholderia pseudomallei-related proteins.
    Nithichanon A; Gourlay LJ; Bancroft GJ; Ato M; Takahashi Y; Lertmemongkolchai G
    Immunology; 2017 May; 151(1):98-109. PubMed ID: 28066900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel multi-component vaccine approaches for Burkholderia pseudomallei.
    Morici L; Torres AG; Titball RW
    Clin Exp Immunol; 2019 May; 196(2):178-188. PubMed ID: 30963550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Virulence of the Melioidosis Pathogen Burkholderia pseudomallei Requires the Oxidoreductase Membrane Protein DsbB.
    McMahon RM; Ireland PM; Sarovich DS; Petit G; Jenkins CH; Sarkar-Tyson M; Currie BJ; Martin JL
    Infect Immun; 2018 May; 86(5):. PubMed ID: 29440370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Burkholderia pseudomallei capsular polysaccharide conjugates provide protection against acute melioidosis.
    Scott AE; Burtnick MN; Stokes MG; Whelan AO; Williamson ED; Atkins TP; Prior JL; Brett PJ
    Infect Immun; 2014 Aug; 82(8):3206-13. PubMed ID: 24866807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenic Burkholderia pseudomallei outer membrane proteins as potential candidate vaccine targets.
    Hara Y; Mohamed R; Nathan S
    PLoS One; 2009 Aug; 4(8):e6496. PubMed ID: 19654871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant Salmonella Expressing Burkholderia mallei LPS O Antigen Provides Protection in a Murine Model of Melioidosis and Glanders.
    Moustafa DA; Scarff JM; Garcia PP; Cassidy SK; DiGiandomenico A; Waag DM; Inzana TJ; Goldberg JB
    PLoS One; 2015; 10(7):e0132032. PubMed ID: 26148026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Melioidosis: a greater threat than previously suspected?
    Kelser EA
    Microbes Infect; 2016 Nov; 18(11):661-668. PubMed ID: 27436814
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Duangurai T; Indrawattana N; Pumirat P
    Biomed Res Int; 2018; 2018():3039106. PubMed ID: 29992136
    [No Abstract]   [Full Text] [Related]  

  • 38. Heterologously type IV pilus expressed protein of Burkholderia pseudomallei is immunogenic but fails to induce protective immunity in mice.
    Sangdee K; Waropastrakul S; Wongratanachewin S; Homchampa P
    Southeast Asian J Trop Med Public Health; 2011 Sep; 42(5):1190-6. PubMed ID: 22299445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of capsular polysaccharide-based glycoconjugates for immunization against melioidosis and glanders.
    Burtnick MN; Heiss C; Roberts RA; Schweizer HP; Azadi P; Brett PJ
    Front Cell Infect Microbiol; 2012; 2():108. PubMed ID: 22912938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A naturally derived outer-membrane vesicle vaccine protects against lethal pulmonary Burkholderia pseudomallei infection.
    Nieves W; Asakrah S; Qazi O; Brown KA; Kurtz J; Aucoin DP; McLachlan JB; Roy CJ; Morici LA
    Vaccine; 2011 Oct; 29(46):8381-9. PubMed ID: 21871517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.